Arcturus Therapeutics
ARCT
$26.63
Share price
0.30%
Change (1 day)
1.95%
Change (1 year)
Operating Margin for Arcturus Therapeutics (ARCT)
Operating Margin as of April 2024 (TTM): 7.61%
According to Arcturus Therapeutics 's latest financial reports and stock price the company's current Operating Margin is 7.61%. At the end of 2021 the company had an Operating Margin of -1,647.98%.
Operating Margin history for Arcturus Therapeutics from 2018 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -1,647.98% | 117.89% |
| 2020 | -756.35% | 504.97% |
| 2019 | -125.02% | -9.59% |
| 2018 | -138.29% | 64.89% |
| 2017 | -83.87% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -234,760.00% | -3,084,988.30% | Bahamas |
 NRC Health
NRC | 32.86% | 331.80% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.